Stock listing
NASDAQ:JNCE Jounce Therapeutics Inc Stock
Follow Jounce Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:JNCE
$1.88 USD
Close on May 5, 2023 · No longer trades
- Lowest – highest close
- $0.64 – $28.46 USDSince Jan 26, 2017 · lowest Dec 12, 2022 · highest May 1, 2017
Delisted NASDAQ:JNCE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:JNCE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Jounce Therapeutics Inc on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
- Decks
- 13 decks · latest Aug 30, 2022
Events
| Call | When | Status |
|---|---|---|
| Jounce Therapeutics (JNCE) Q3 2022 Earnings Call | Thu, Nov 10, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q1 2022 Earnings Call | Thu, May 05, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q4 2021 Earnings Call | Wed, Mar 02, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q1 2021 Earnings Call | Tue, May 04, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 34 slides | Aug 30, 2022 |
| Investor Presentation (March 2022) | Investor deck | 33 slides | Mar 7, 2022 |
| Investor Presentation (January 2022) | Investor deck | 31 slides | Jan 10, 2022 |
| Investor Presentation (January 2021) | Investor deck | 26 slides | Jan 11, 2021 |
| Investor Presentation (April 2020) | Investor deck | 28 slides | Apr 7, 2020 |
| Investor Presentation (January 2020) | Investor deck | 26 slides | Jan 13, 2020 |
| Investor Presentation (September 2019) | Investor deck | 22 slides | Sep 4, 2019 |
| Investor Presentation (January 2019) | Investor deck | 25 slides | Jan 7, 2019 |
| Investor Presentation (November 2018) | Investor deck | 29 slides | Nov 9, 2018 |
| 2018 American Society of Clinical Oncology Annual Meeting | Conference | 24 slides | Jun 5, 2018 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2018) | Technical | 18 slides | Jun 4, 2018 |
| Investor Presentation (January 2018) | Investor deck | 25 slides | Jan 8, 2018 |
| AACR Annual Meeting 2017 | Conference | 27 slides | Apr 3, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Iannone Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jul 9, 2026); Autolus Therapeutics plc (Chair of the Research & Development Committee · Since at least Mar 18, 2026); Jazz Pharmaceuticals plc (EVP, Global Head of R&D & CMO · Since at least May 29, 2019); Iteos Therapeutics Inc (Director · Apr 29, 2021 – Jun 11, 2024 · Past); Immunomedics Inc (CHIEF MEDICAL OFFICER · Apr 12, 2018 – Mar 14, 2019 · Past) | Director · Jan 21, 2020 – May 3, 2023 · Past |
| Kevin Tang Other companies: Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 12, 2024); Heron Therapeutics, Inc. (Director · Dec 22, 2015 – Dec 31, 2019 · Past); La Jolla Pharmaceutical Co (Director · Aug 19, 2015 – Aug 22, 2022 · Past) | Director · May 3, 2023 – May 3, 2023 · Past |
| Hugh M Cole Other companies: Astria Therapeutics Inc (Director · Since at least Jul 26, 2019); Ariad Pharmaceuticals Inc (SVP, Chief Business Officer · Apr 29, 2016 – Feb 16, 2017 · Past) | Chief Operating Officer · Dec 20, 2017 – Jan 9, 2023 · Past |
| John Duncan Higgons Other companies: Agios Pharmaceuticals, Inc. (Chief Operating Officer · Jul 23, 2013 – Jan 4, 2016 · Past) | Director · Jan 26, 2017 – Jun 24, 2022 · Past |
Log in to ask 6ix AI your own questions about Jounce Therapeutics Inc.